buthionine sulfoximine has been researched along with Chagas Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faúndez, M; Ferreira, J; Kemmerling, U; López-Muñoz, R; Maya, JD; Morello, A; Orellana, M; Torres, G | 1 |
1 other study(ies) available for buthionine sulfoximine and Chagas Disease
Article | Year |
---|---|
Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox.
Topics: Acute Disease; Animals; Buthionine Sulfoximine; Chagas Disease; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Mice; Mice, Inbred BALB C; Nifurtimox; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2008 |